<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22932217</PMID><DateCompleted><Year>2013</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>9</Issue><PubDate><Year>2012</Year><Month>Aug</Month><Day>29</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Antiviral effect of matrine against human enterovirus 71.</ArticleTitle><Pagination><StartPage>10370</StartPage><EndPage>10376</EndPage><MedlinePgn>10370-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules170910370</ELocationID><Abstract><AbstractText>Human enterovirus 71, a member of the Picornaviridae family, is one of the major causative agent of hand, foot and mouth disease in children less than six years old. This illness has caused mortalities in large-scale outbreaks in the Asia-Pacific region in recent years. No vaccine or antiviral therapy is available. In this study, antiviral effect of matrine against enterovirus 71 were evaluated in vitro and in vivo. Matrine could suppress the viral RNA copy number on rhabdomyosarcoma cells. Moreover, matrine treatment of mice challenged with a lethal dose of enterovirus 71 reduced the mortality and relieved clinical symptoms. The results showed that matrine may represent a potential therapeutic agent for enterovirus 71 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yajun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health, Institute of Laboratory Animal Science, Chines Academy of Medical Science &amp; Comparative Medicine Centre, Peking Union Medical College, Beijing 100021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiu</LastName><ForeName>Jinghui</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xu</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Liangfeng</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Kai</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Chuan</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jiangning</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000470">Alkaloids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011807">Quinolizines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000093842">Matrines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000470" MajorTopicYN="N">Alkaloids</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011807" MajorTopicYN="N">Quinolizines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000093842" MajorTopicYN="N">Matrines</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2012</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22932217</ArticleId><ArticleId IdType="pmc">PMC6268984</ArticleId><ArticleId IdType="doi">10.3390/molecules170910370</ArticleId><ArticleId IdType="pii">molecules170910370</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chang L.Y. Enterovirus 71 in Taiwan. Pediatr. Neonatol. 2008;49:103&#x2013;112. doi: 10.1016/S1875-9572(08)60023-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1875-9572(08)60023-6</ArticleId><ArticleId IdType="pubmed">19054914</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasri D., Bouslama L., Pillet S., Bourlet T., Aouni M., Pozzetto B. Basic rationale, Current methods and future directions for molecular typing of human enterovirus. Expert Rev. Mol. Diagn. 2007;7:419&#x2013;434. doi: 10.1586/14737159.7.4.419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737159.7.4.419</ArticleId><ArticleId IdType="pubmed">17620049</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L., Lu J., Kung H., He M.L. The virology and developments toward control of human enterovirus 71. Crit. Rev. Microbiol. 2011;37:1&#x2013;15. doi: 10.3109/1040841X.2010.501760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/1040841X.2010.501760</ArticleId><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.J., Zhang L.F., Fan X.X., Qin C., Liu J.N. Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo. Bioorg. Med. Chem. Lett. 2012;22:2209&#x2013;2211. doi: 10.1016/j.bmcl.2012.01.102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2012.01.102</ArticleId><ArticleId IdType="pubmed">22342145</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Song Z.L., Qi Y.H., Feng X.F., Xu N.Q., Sun Y.Y., Wu X., Yao X., Mao Q.Y., Li X.L., et al. Molecular determinants of enterovirus 71 viral entry: Cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J. Biol. Chem. 2012;287:6406&#x2013;6420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K.X., Ng M.M., Chu J.J. Developments towards antiviral therapies against enterovirus 71. Drug Discov. Today. 2010;15:1041&#x2013;1051. doi: 10.1016/j.drudis.2010.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2010.10.008</ArticleId><ArticleId IdType="pmc">PMC7108380</ArticleId><ArticleId IdType="pubmed">20974282</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z.F., Mao L., Liu L.M., Liu Y.C., Peng Y., Hong X., Wang H.H., Liu H.G., Liang H. Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) matrine with Ga(III), Au(III), Sn(IV) ions, and DNA binding studies. J. Inorg. Biochem. 2011;105:171&#x2013;180. doi: 10.1016/j.jinorgbio.2010.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinorgbio.2010.10.007</ArticleId><ArticleId IdType="pubmed">21194615</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L.S., You Y.J., Wang S.Q., Liu X., Liu B.M., Wang J.N., Lin X., Chen M.S., Liang G., Yang H. Synthesis, Characterization and in vitro anti-tumor activities of matrine derivatives. Bioorg. Med. Chem. Lett. 2012;22:4100&#x2013;4102.</Citation><ArticleIdList><ArticleId IdType="pubmed">22578453</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z.H., Li C.M., Ling P., Shen F.H., Chen S.H., Liu C.C., Yu C.K., Chen S.H. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J. Infect. Dis. 2008;197:854&#x2013;857. doi: 10.1086/527326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/527326</ArticleId><ArticleId IdType="pmc">PMC7109938</ArticleId><ArticleId IdType="pubmed">18279075</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng T.Y., Chen L.C., Shyu H.W., Chen S.H., Wang J.R., Yu C.K., Lei H.Y., Yeh T.M. Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. Antiviral. Res. 2005;67:31&#x2013;37. doi: 10.1016/j.antiviral.2005.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2005.03.005</ArticleId><ArticleId IdType="pubmed">15916817</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim A.C., Luhur A., Tan T.M., Chow V.T., Poh C.L. RNA interference against enterovirus 71 infection. Virology. 2005;341:72&#x2013;79. doi: 10.1016/j.virol.2005.06.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2005.06.047</ArticleId><ArticleId IdType="pubmed">16083932</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M.L., Lee Y.P., Wang Y.F., Lei H.Y., Liu C.C., Wang S.M., Su I.J., Wang J.R., Yeh T.M., Chen S.H., et al. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 2005;86:3263&#x2013;3269.</Citation><ArticleIdList><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L.M., Han Y.X., Wang Y.P., Li Y.H., Shan Y.Q., Li X., Peng Z.G., Bi C.W., Zhang T., Du N.N., et al. Design and synthesis of oxymatrine analogues overcoming drug resistance in hepatitis B virus through targeting host Heat stress cognate 70. J. Med. Chem. 2011;54:869&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pubmed">21218816</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.Y., Zhu H.Y., Ye G., Huang C.G., Yang Y.Z., Chen R.Z., Yu Y., Cui X.L. Antiviral effects of sophoridine against coxsackievirus B3 and its pharmacokinetics in rats. Life Sci. 2006;78:1998&#x2013;2005.</Citation><ArticleIdList><ArticleId IdType="pubmed">16309710</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J.N., Yang Y.J., Xu Y.F., Ma C.M., Qin C., Zhang L.F. Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication. Viol. J. 2011;8:483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3212826</ArticleId><ArticleId IdType="pubmed">22029605</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael J.P. Indolizidine and quinolizidine alkaloids. Nat. Prod. Rep. 2001;18:520&#x2013;542. doi: 10.1039/b005384h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/b005384h</ArticleId><ArticleId IdType="pubmed">11699884</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>